Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Free Cash Flow: 2019-2024

Historic Free Cash Flow for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $123.6 million.

  • Cellebrite DI's Free Cash Flow fell 15.82% to $36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.1 million, marking a year-over-year increase of 40.34%. This contributed to the annual value of $123.6 million for FY2024, which is 27.66% up from last year.
  • As of FY2024, Cellebrite DI's Free Cash Flow stood at $123.6 million, which was up 27.66% from $96.8 million recorded in FY2023.
  • Cellebrite DI's Free Cash Flow's 5-year high stood at $123.6 million during FY2024, with a 5-year trough of $13.7 million in FY2022.
  • For the 3-year period, Cellebrite DI's Free Cash Flow averaged around $78.0 million, with its median value being $96.8 million (2023).
  • In the last 5 years, Cellebrite DI's Free Cash Flow plummeted by 55.79% in 2022 and then soared by 607.80% in 2023.
  • Over the past 5 years, Cellebrite DI's Free Cash Flow (Yearly) stood at $60.3 million in 2020, then tumbled by 48.71% to $30.9 million in 2021, then plummeted by 55.79% to $13.7 million in 2022, then skyrocketed by 607.80% to $96.8 million in 2023, then rose by 27.66% to $123.6 million in 2024.